IP Library › Assignment 010232/0954
Patent Assignment
Reel/Frame 010232/0954

Assignment of Assignor's Interest

Recorded: 1999-09-13 Pages: 3
Assignors
JOSHI, PHALGUN B.
Executed: 1999-08-23
GRAHAM, ROGER W.
Executed: 1999-07-23
Assignee
INEX PHARMACEUTICALS CORPORATION
GLENLYON BUSINESS PARK, 100-8900 GLENLYON PARKWAY, BURNABY, B.C., V6K 3, CANADA
Covered Property (1)
Combination Therapy Using Nucleic Acids and Radio Therapy
Patent: 6,841,538 →
Application: 09/295,925 →
Related Assignments (5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Sep 13, 1999
From: DURAND, RALPH E.
To: BRITISH COLUMBIA CANCER AGENCY
Reel/Frame 010232/0951 →
Assignment of Assignor's Interest Apr 22, 2002
From: INEX PHARMACEUTICALS CORPORATION
To: PROTIVA BIOTHERAPEUTICS INC.
Reel/Frame 012840/0724 →
Security Agreement Dec 29, 2011
From: PROTIVA BIOTHERAPEUTICS, INC.
To: SILICON VALLEY BANK
Reel/Frame 027463/0613 →
Merger Feb 20, 2018
From: PROTIVA BIOTHERAPEUTICS INC.
To: ARBUTUS BIOPHARMA CORPORATION
Reel/Frame 045384/0278 →
Release of Security Interest Feb 16, 2023
From: SILICON VALLEY BANK
To: PROTIVA BIOTHERAPEUTICS, INC.
Reel/Frame 062721/0199 →